PRMT5 Inhibitors and Uses Thereof (2013)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/790,525, filed Mar 15, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,993,555 | PRMT5 Inhibitors and Uses Thereof In force · High confidence UsedRemaining | Epizyme, Inc. | In force | High confidence | ||
| US 9,365,519 | PRMT5 Inhibitors and Uses Thereof In force · High confidence | Epizyme, Inc. | In force | High confidence | ||
| US 9,675,614 | PRMT5 Inhibitors and Uses Thereof In force · High confidence | Epizyme, Inc. | In force | High confidence | ||
| US 10,391,089 | PRMT5 Inhibitors and Uses Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| US 10,980,794 | PRMT5 Inhibitors and Uses Thereof In force · Medium confidence | Epizyme, Inc. | In force | Medium confidence | ||
| Application 15/586,775 | PRMT5 Inhibitors and Uses Thereof Abandoned Abandoned Apr 4, 2018 | Epizyme, Inc. | Abandoned | Abandoned Apr 4, 2018 | ||
| Application 17/189,989 | PRMT5 Inhibitors and Uses Thereof Abandoned Abandoned Dec 6, 2023 | Epizyme, Inc. | Abandoned | Abandoned Dec 6, 2023 | ||
| Application 18/487,545 | PRMT5 Inhibitors and Uses Thereof Abandoned Abandoned Jun 18, 2024 | Epizyme, Inc. | Abandoned | Abandoned Jun 18, 2024 | ||
| Application 18/743,249 | PRMT5 Inhibitors and Uses Thereof Abandoned Abandoned Jan 29, 2025 | Epizyme, Inc. | Abandoned | Abandoned Jan 29, 2025 | ||
| Application 19/028,189 | PRMT5 Inhibitors and Uses Thereof Pending Not granted | Epizyme, Inc. | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Epizyme, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.